Evidence map›Paper›PMID 39251572›Full record

ArticleCell death & disease2024

Cilia defects upon loss of WDR4 are linked to proteasomal hyperactivity and ubiquitin shortage.

Martin D Burkhalter, Tom Stiff, Lars D Maerz, Teresa Casar Tena, Heike Wiese, Julian Gerhards, Steffen A Sailer, Linh Anna Trúc Vu, Max Duong Phu, Cornelia Donow and 7 more

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Martin D BurkhalterDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.
Tom StiffGenome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.
Lars D MaerzInstitute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.
Teresa Casar TenaInstitute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.
Heike WieseCore Unit Mass Spectrometry and Proteomics, Medical Faculty, Ulm University, 89081, Ulm, Germany.
Julian GerhardsDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.
Steffen A SailerDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.ORCID 0000-0002-3804-0986
Linh Anna Trúc VuDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.
Max Duong PhuDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.
Cornelia DonowInstitute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.
Marius AlupeiDepartment of Dermatology, Ulm University, 89081, Ulm, Germany.
Sebastian IbenDepartment of Dermatology, Ulm University, 89081, Ulm, Germany.ORCID 0000-0002-5207-2861
Marco GrothCore Facility Next Generation Sequencing, Leibniz Institute on Aging-Fritz Lipmann Institute, 07745, Jena, Germany.ORCID 0000-0002-9199-8990
Sebastian WieseCore Unit Mass Spectrometry and Proteomics, Medical Faculty, Ulm University, 89081, Ulm, Germany.ORCID 0000-0001-5697-2608
Joseph A ChurchDepartment of Pediatrics, Keck School of Medicine of University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, 90033, USA.
Penelope A JeggoGenome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.ORCID 0000-0002-8481-1462
Melanie PhilippDepartment of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany. melanie.philipp@uni-tuebingen.de.ORCID 0000-0003-2714-965X

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 467868420Deutsche Forschungsgemeinschaft (German Research Foundation) PH144/4-1Deutsche Forschungsgemeinschaft (German Research Foundation) PH144/4-3Deutsche Forschungsgemeinschaft (German Research Foundation) PH144/6-1Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1074
6 · The paper itself

Abstract

The WD repeat-containing protein 4 (WDR4) has repeatedly been associated with primary microcephaly, a condition of impaired brain and skull growth. Often, faulty centrosomes cause microcephaly, yet aberrant cilia may also be involved. Here, we show using a combination of approaches in human fibroblasts, zebrafish embryos and patient-derived cells that WDR4 facilitates cilium formation. Molecularly, we associated WDR4 loss-of-function with increased protein synthesis and concomitant upregulation of proteasomal activity, while ubiquitin precursor pools are reduced. Inhibition of proteasomal activity as well as supplementation with free ubiquitin restored normal ciliogenesis. Proteasome inhibition ameliorated microcephaly phenotypes. Thus, we propose that WDR4 loss-of-function impairs head growth and neurogenesis via aberrant cilia formation, initially caused by disturbed protein and ubiquitin homeostasis.

Indexed as

CiliaProteasome Endopeptidase ComplexUbiquitinZebrafishAnimalsFibroblastsGTP-Binding ProteinsHumansMicrocephalyNeurogenesisGTP-Binding ProteinsProteasome Endopeptidase ComplexUbiquitinWDR4 protein, human

Identifiers

PMID39251572
PMCPMC11384789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.